Dassault Systèmes Partners with Sanofi to Optimize Tech Transfer and Industrialization

By OEM Update Editorial October 27, 2022 3:09 pm

Sanofi will use the 3DEXPERIENCE platform to design, implement, qualify and operate modular production lines at its new-generation “EVolutive Facilities” (EVF) in France and Singapore.
Dassault Systèmes and Sanofi today announced their partnership to optimize “EVolutive Facility” production at Sanofi’s future state-of-the-art modular manufacturing facilities in France and Singapore.  The partnership, which expands their long-standing collaboration in life sciences and healthcare, will leverage virtual twin experiences to enable agile and flexible operations that advance Sanofi’s ambition to secure its product portfolio.
Sanofi will use Dassault Systèmes’ “Made to Cure for BioPharma” industry solution experience based on the 3DEXPERIENCE platform to design, implement, qualify and operate modular production lines at the two “EVolutive Facilities.” These will rely on single-use technology and mobile equipment to manufacture up to four products simultaneously and sustainably by selecting the most advanced technologies to reduce their energy consumption. The platform provides a virtual environment for collaborative innovation and end-to-end data management across the life cycle.  Sanofi can experience the manufacturing systems under development and their operation virtually and optimize scale up and industrialization processes before deploying them.

Advertising

Your future advertising space? Our media data